BioSyent Inc. BIOYF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 41.61% | 46.14% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 41.61% | 46.14% | |||
| Cost of Revenue | 56.43% | 70.78% | |||
| Gross Profit | 36.16% | 38.78% | |||
| SG&A Expenses | 40.37% | 21.28% | |||
| Depreciation & Amortization | 112.68% | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 49.49% | 42.75% | |||
| Operating Income | 17.70% | 57.49% | |||
| Income Before Tax | 19.77% | 34.71% | |||
| Income Tax Expenses | 18.10% | 96.45% | |||
| Earnings from Continuing Operations | 20.44% | 19.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 20.44% | 19.64% | |||
| EBIT | 17.70% | 57.49% | |||
| EBITDA | 28.96% | 63.41% | |||
| EPS Basic | 19.83% | 18.83% | |||
| Normalized Basic EPS | 14.62% | 44.88% | |||
| EPS Diluted | 20.16% | 18.69% | |||
| Normalized Diluted EPS | 14.81% | 44.87% | |||
| Average Basic Shares Outstanding | 0.50% | 0.66% | |||
| Average Diluted Shares Outstanding | 0.27% | 0.77% | |||
| Dividend Per Share | -1.00% | 11.70% | |||
| Payout Ratio | -0.17% | -0.07% | |||